| Date Filed | Type | Description |
| 08/18/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 9.9% stake in Kiniksa Pharmaceuticals, Ltd. |
| 06/30/2023 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 8.3% stake in I-MAB |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 6.4% stake in Cytek Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.3% stake in Gossamer Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 7.6% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 11.9% stake in MOGU Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 15.6% stake in Bright Scholar Education Holdings Limited |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 19.1% stake in Yatsen Holding Ltd. |
| 08/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G
| HHLR ADVISORS, LTD. reports a 5.3% stake in On Holding AG |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 3.3% stake in KE Holdings Inc. |
| 02/14/2022 |
SC 13G
| HHLR ADVISORS, LTD. reports a 6.5% stake in Cytek Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.6% stake in Aligos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a |
| 02/14/2022 |
SC 13G
| HHLR ADVISORS, LTD. reports a 5.8% stake in Agora, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Leap Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Beam Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Apellis Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 18% stake in Yatsen Holding Ltd. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.2% stake in Root, Inc. |
| 09/27/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/27/2021 |
SC 13G
| HHLR ADVISORS, LTD. reports a 14.7% stake in Smart Share Global Limited |
| 07/19/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 0% stake in Enstar Group Limited |
| 06/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/25/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 11.3% stake in I-MAB |
| 02/16/2021 |
SC 13G
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 5.7% stake in Aligos Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|